Scoring Tool Ranks Pediatric Vancomycin PK Models for Precision Dosing
This systematic review catalogs 112 neonatal and pediatric vancomycin population pharmacokinetic models and provides a transparent, expert-weighted scoring tool to select the best model for model-informed precision dosing.
📅 Journal publication: Jul 2026(online Mar 24, 2026)·Last updated: Oct 5, 2026
Optimize vancomycin dosing with precision models in young patients.
Vancomycin dosing in neonates and children is challenging due to variability in pharmacokinetics, making precision dosing crucial for efficacy and safety. Among 112 models identified, the study highlights the Chen (2023) model as the best for neonatal and pediatric populations based on comprehensive evaluation. The review provides a standardized tool for selecting appropriate pharmacokinetic models, enhancing model-informed precision dosing for vancomycin in young patients. The Chen (2023) popPK model is recommended for vancomycin precision dosing in neonates and children.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Vander Elst Z, Spiessens PJ, Vanneste D, Dia N, Gijsen M, Spriet I, Allegaert K, Dreesen E, Smits A
Citation:Vander Elst Z, Spiessens PJ, Vanneste D, et al. Systematic review and scoring-based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children. British journal of clinical pharmacology. 2026;92(7):2028-2048. doi:10.1002/bcp.70530